Aptevo Therapeutics (APVO) Stock Price
$0.34 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
1
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Aptevo Therapeutics, AI stock picks, stock alerts and much more.
APVO AI Stock Analysis
AI stock analysis for APVO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aptevo Therapeutics (APVO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Aptevo Therapeutics (APVO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aptevo Therapeutics (APVO), currently trading at $0.34, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About APVO
-
Aptevo Therapeutics Inc.
-
Symbol
APVO
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.37 2.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.8 1.1% |
1 |
 |
Moderna MRNA |
$24.25 0.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.25 3.6% |
5 |
 |
BridgeBio Pharma BBIO |
$34.17 2% |
6 |
News
APVO Alternative Data
Web Traffic
Aptevo Therapeutics receives an estimated 1670 monthly visitors to aptevotherapeutics.com, which is up by 10.4% over the last month.
-
Web Traffic
1670
-
Change from Previous Month
10.4%
-
3 Month Change
25.5%
-
YoY Change
25.5%
LinkedIn Followers
3,780 are following Aptevo Therapeutics on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
3780
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
4.8%
Job Postings
Aptevo Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Aptevo Therapeutics has 62 employees, up by 1.6% over the last month.
-
LinkedIn Employees
62
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Aptevo Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
Aptevo Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Aptevo Therapeutics is 72 out of 100 (bullish).
-
Business Outlook
72
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
APVO Financials
APVO Key Metrics
-
Total Revenue
$0
-
Net Income
-$6.3M
-
Earnings per Share
-$22.15
-
Free cash flow
-$5.8M
-
EBITDA
-$6.3M
-
EBITDA Ratio
0
-
Total Assets
$15.6M
APVO 2-year Revenue & Income
APVO 2-year Free Cash Flow
APVO Technicals
APVO SMA
APVO RSI
FAQ
What's the current price of Aptevo Therapeutics (APVO) Stock?
The price of an Aptevo Therapeutics (APVO) share is $0.34.
What's the market cap of Aptevo Therapeutics?
The current market cap of Aptevo Therapeutics is 2.1M.
Should I buy or sell APVO?
Aptevo Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Aptevo Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Aptevo Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Aptevo Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Aptevo Therapeutics (APVO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Aptevo Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Aptevo Therapeutics (APVO) that investors often compare it to?
Aptevo Therapeutics (APVO) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Aptevo Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aptevo Therapeutics' stock price to be around $0.317 in 2026. Starting from the current price of $0.34, this represents a 6.8% change in price, indicating a bearish outlook for the stock.
How to buy Aptevo Therapeutics (APVO) Stock?
Aptevo Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aptevo Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.